Skip to main content
. 2020 Jul 14;19:112. doi: 10.1186/s12933-020-01077-6

Table 3.

Association of the TyG index, glycemic, lipid parameters with HTN by sex in Model 2

Variable Male Female
OR (95% CI) P-value OR (95% CI) P-value
TG, mmol/L
 < 1.7 1.0 1.0
 ≥ 1.7, < 2.3 1.22 (1.02, 1.47) 0.0336 1.24 (1.10, 1.40) 0.0003
 ≥ 2.3 1.14 (0.96, 1.36) 0.1377 1.18 (1.04, 1.33) 0.0098
TC, mmol/L
 < 5.2 1.0 1.0
 ≥ 5.2, < 6.2 0.89 (0.76, 1.04) 0.1454 0.95 (0.86, 1.06) 0.3689
 ≥ 6.2 0.98 (0.78, 1.24) 0.8749 0.87 (0.77, 0.99) 0.0289
HDL-C, mmol/L
 ≥ 1 1.0 1.0
 < 1 1.36 (1.16, 1.58) < 0.0001 1.20 (1.04, 1.39) 0.0128
LDL-C, mmol/L
 < 3.4 1.0 1.0
 ≥ 3.4, < 4.1 0.99 (0.83, 1.18) 0.9088 1.00 (0.89, 1.11) 0.9433
 ≥ 4.1 1.15 (0.89, 1.48) 0.2941 0.97 (0.84, 1.11) 0.6651
TYG ln transform Q5
 Q1 1.0 1.0
 Q2 1.05 (0.85, 1.32) 0.6358 1.05 (0.91, 1.22) 0.4763
 Q3 1.27 (1.02, 1.59) 0.0309 1.01 (0.88, 1.17) 0.8498
 Q4 1.39 (1.11, 1.74) 0.0042 1.28 (1.11, 1.49) 0.0010
 Q5 1.19 (0.95, 1.51) 0.1376 1.25 (1.07, 1.47) 0.0057
HbA1c, %
 < 6.5 1.0 1.0
 ≥ 6.5 0.76 (0.59, 0.97) 0.0292 1.05 (0.89, 1.24) 0.5480
PBG, mmol/L
 < 11.1 1.0 1.0
 ≥ 11.1 0.97 (0.77, 1.22) 0.7897 1.17 (0.98, 1.40) 0.0798

Model 2: Adjusted for age; center; history of CVDs; history of T2DM; hypoglycemic drugs; SBP; DBP; BMI; ALT; AST; WHR; eGFR; smoking habits; drinking habits